Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Managing Pacemaker Leads in Tricuspid Valve Interventions
Author(s): Devi Nair , Laurence Epstein , Robert D Schaller Added: 3 months ago
In this essential episode of Rhythm Interventions Unplugged, host Dr Devi Nair (St. Bernard's Medical Center, US) sits down with two leading experts in cardiac device management: Dr Larry Epstein and Dr Robert Schaller. Together, they explore a critical challenge facing electrophysiologists today - managing pacemaker and ICD leads in patients requiring tricuspid valve interventions.Dr Epstein and… View more

Electrophysiology & Arrhythmia
Transcatheter Electrosurgery in Structural Heart Interventions
Author(s): Chak-yu So , Leo Kar Lok Lai , Ling Na Wong , et al Added: 1 year ago

Vascular Disease and Surgery

Intervention
TCT 24: The TRISCEND II Trial
Author(s): Susheel Kodali Added: 1 year ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter tricuspid valve replacement (TTVR) compared to optimal medical therapy for patients with severe tricuspid regurgitation (TR).Dr Susheel Kodali (Columbia University Medical Center, New York, US) joins us onsite at TCT Conference to discuss the findings from the TRISCEND II Trial (NCT04482062; Edwards Lifesciences).TRISCEND II is a… View more

Intervention
ACCURATE Neo2 in Rheumatic Aortic Stenosis
Author(s): Ivan Wong , Michael Chiang , Angus Shing Fung Chui , et al Added: 1 year ago

Intervention

Vascular Disease and Surgery
EuroPCR 25: The TRICURE EU Study
Author(s): Julien Dreyfus Added: 7 months ago
EuroPCR 25 - First-in-human outcomes from the TRiCares Topaz Tricuspid Valve Replacement System in patents with tricuspid regurgitation (TR) show positive performance results and improved safety.We are joined by Dr Julien Dreyfus (Centre Cardiologique du Nord, Saint-Denis, FR) to discuss outcomes from the first-in-human, pivotal, multi-centre TRICURE EU study (NCT06581471; TRiCares) investigating… View more

Intervention
EuroPCR 25: The FATE Registry
Author(s): Fedrico de Marco Added: 7 months ago
EuroPCR 2025 - Outcomes from the FATE Registry show coapttion gaps are at the upper limit of treatability in this patient group using current tTEER devices.Dr Fedrico de Marco (Centro Cardiologico Monzino IRCCS, Milan, IT) joins us to discuss the management and outcomes from the FATE registry, which investigated 123 case of failed tricuspid transcatheter edge-to-edge repair (tTEER) with all… View more

Intervention
Managing LVOT Obstruction in Transcatheter Mitral Replacement with Dr Eleid
Author(s): Mackram F Eleid Added: 2 months ago
Explore advanced strategies for preventing and managing LVOT obstruction in transcatheter mitral valve replacement with Dr Mackram EleidThis presentation, part of Women As One's comprehensive Structural Interventions track, examines of a 90-year-old patient with severe mitral annular calcification, heart failure with preserved ejection fraction, and significant basal septal hypertrophy. Dr Eleid… View more

Intervention
APSC Position Statement on TAVI for Aortic Stenosis
Author(s): Jonathan Yap , Kentaro Hayashida , Michael Kang-Yin Lee , et al Added: 1 year ago

Intervention
TCT 25 Structural Interventions Highlights
Author(s): Nadira Hamid , Rahul P Sharma Added: 2 months ago
TCT 2025 — Dr Nadira Hamid (Minneapolis Heart Institute, US) and Dr Rahul P Sharma (Stanford University, US) review the late-breaking trial data shaping the future of structural heart disease.The discussion highlights real-world results from TRISCEND and TRILUMINATE in tricuspid disease, 7-year PARTNER 3 durability outcomes in TAVR, national prevalence insights from the PREVUE-VALVE study, and… View more

Intervention
NY Valves 25: TRISCEND II Substudy
Author(s): Added: 6 months ago
New York Valves 25 - A substudy of TRISCEND II investigating the effect of transcatheter tricuspid valve replacement (TTVR) on preference-weighted health status showed significant benefits in patients who received TTVR.We are joined by Dr Suzanne Arnold (Saint Luke's Mid America Heart Institute, US) to discuss the findings from a substudy of the TRISCEND II trial, which aimed to create an… View more

Intervention